Wout Brusselaers holds the position of Co-founder and CEO at Deep 6 AI. The company under his leadership utilizes AI for patient matching and clinical trial recruitment in drug discovery, being a pioneering force in Clinical Trial Acceleration Software (CTAS). Deep 6 AI employs AI and NLP techniques on clinical data to facilitate health systems, life sciences companies, CROs, and patients in expediting the introduction of novel treatments to the market, thereby accelerating healthcare innovation